VC005 Placebo group
Sponsors
Jiangsu vcare pharmaceutical technology co., LTD
Conditions
Atopic DermatitisModerate to Severe Atopic Dermatitis
Phase 2
Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis
CompletedNCT06891040
Start: 2025-04-28End: 2025-11-04Updated: 2026-04-13
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
RecruitingNCT07598383
Start: 2026-06-01End: 2027-02-22Target: 120Updated: 2026-07-07